Increased EZH2 expression in prostate cancer is associated with metastatic recurrence following external beam radiotherapy

BACKGROUND: Enhancer of zeste 2 (EZH2) promotes prostate cancer progression. We hypothesized that increased EZH2 expression is associated with postradiotherapy metastatic disease recurrence, and may promote radioresistance. METHODS: EZH2 expression was investigated using immunohistochemistry in diag...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Prostate
Main Authors: Wu, Xiaoning, Scott, Helen, Carlsson, Sigrid V., Sjoberg, Daniel D., Cerundolo, Lucia, Lilja, Hans, Prevo, Remko, Rieunier, Guillaume, Macaulay, Valentine, Higgins, Geoffrey S., Verrill, Clare L., Lamb, Alastair D., Cunliffe, Vincent T., Bountra, Chas, Hamdy, Freddie C., Bryant, Richard J.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6563086/
https://ncbi.nlm.nih.gov/pubmed/31104332
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.23817
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados